This database analysis shows that (1) about every other patient with diabetes is screened for the presence of CKD annually; (2) less than half of patients achieve a target HbA1c of < 7.0 % (or < 53 mmol/mol); recommended use of SGLT-2i and GLP1-RA is well below 10 %; (3) hypertension is controlled in about two-thirds of patients with lower rates depending on age and respective SBP thresholds; RAAS blockers are used in about half of the patients. The gene discussed is GLP1R; the disease is hypertensive disorder.